These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1825795)

  • 21. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus.
    Murphy M; Epstein LB
    Clin Immunol Immunopathol; 1992 Feb; 62(2):245-51. PubMed ID: 1530912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repopulation of circulating T, B and NK lymphocytes following bone marrow and blood stem cell transplantation.
    Parrado A; Casares S; Prieto J; Carmona M; Vaquero A; Rodríguez-Fernández JM
    Hematol Cell Ther; 1997 Dec; 39(6):301-6. PubMed ID: 9497889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV; Funahashi A
    Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of interleukin 2-expanded human peripheral blood lymphocytes: not only NKH-1+-NK cells but also NKH-1+ and NKH-1- T cells are LAK effectors.
    Saito H; Oshimi K; Oshimi Y; Mizoguchi H
    Cell Immunol; 1988 Dec; 117(2):253-63. PubMed ID: 3058317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of blood cell populations, plasma zinc and natural killer cell activity in young children with Down's syndrome.
    Noble RL; Warren RP
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():193-201. PubMed ID: 2971114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses.
    Wang EC; Taylor-Wiedeman J; Perera P; Fisher J; Borysiewicz LK
    Clin Exp Immunol; 1993 Nov; 94(2):297-305. PubMed ID: 7693383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of large and small CD3- CD56+ lymphocytes mediating NK-associated activities.
    Ortaldo JR; Winkler-Pickett R; Kopp W; Kawasaki A; Nagashima K; Okumura K; Yagita H; Bach FH
    J Leukoc Biol; 1992 Sep; 52(3):287-95. PubMed ID: 1381742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
    Vidriales MB; Orfao A; López-Berges MC; González M; Hernandez JM; Ciudad J; López A; Moro MJ; Martínez M; San Miguel JF
    Ann Hematol; 1993 Nov; 67(5):217-22. PubMed ID: 7694663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.
    Ortaldo JR; Winkler-Pickett RT; Yagita H; Young HA
    Cell Immunol; 1991 Sep; 136(2):486-95. PubMed ID: 1714795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-γ production by tubulointerstitial human CD56
    Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
    Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective detection of human hepatitis B virus surface and core antigens in some peripheral blood mononuclear cell subsets by flow cytometry.
    Chemin I; Vermot-Desroches C; Baginski I; Saurin JC; Laurent F; Zoulim F; Bernaud J; Lamelin JP; Hantz O; Rigal D
    J Clin Lab Immunol; 1992; 38(2):63-71. PubMed ID: 1343349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia.
    Wilczyński JR; Tchórzewski H; Banasik M; Głowacka E; Wieczorek A; Lewkowicz P; Malinowski A; Szpakowski M; Wilczyński J
    Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):8-15. PubMed ID: 12818436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological features of Down's syndrome: a review.
    Nespoli L; Burgio GR; Ugazio AG; Maccario R
    J Intellect Disabil Res; 1993 Dec; 37 ( Pt 6)():543-51. PubMed ID: 8124000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.
    McNerlan SE; Rea IM; Alexander HD; Morris TC
    J Clin Immunol; 1998 Jan; 18(1):31-8. PubMed ID: 9475351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
    Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of monocytes in the expansion of human activated natural killer cells.
    Miller JS; Oelkers S; Verfaillie C; McGlave P
    Blood; 1992 Nov; 80(9):2221-9. PubMed ID: 1421393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.